Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma ; volume:12 ; number:1 ; day:23 ; month:7 ; year:2019 ; pages:1 ; date:12.2019
Journal of ovarian research ; 12, Heft 1 (23.7.2019), 1, 12.2019
- Urheber
-
Kim, Ki Hyung
Choi, Kyung Un
Kim, Ahrong
Lee, So Jung
Lee, Jung Hee
Suh, Dong Soo
Kwon, Byung-Su
Hwang, Chungsu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-019-0540-2
- URN
-
urn:nbn:de:101:1-2019121705403955314196
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Ki Hyung
- Choi, Kyung Un
- Kim, Ahrong
- Lee, So Jung
- Lee, Jung Hee
- Suh, Dong Soo
- Kwon, Byung-Su
- Hwang, Chungsu
- SpringerLink (Online service)
Ähnliche Objekte (12)
PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors
Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma
Tumor-Infiltrating Lymphocytes in Wilms Tumor
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis
The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma
Quantifying tumor-infiltrating immune cells from transcriptomics data
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors
Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma
Tumor-Infiltrating Lymphocytes in Wilms Tumor
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis
The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma
Quantifying tumor-infiltrating immune cells from transcriptomics data
Relevance of tumor-infiltrating lymphocytes in breast cancer
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors
Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma
Tumor-Infiltrating Lymphocytes in Wilms Tumor
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis
The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma
Quantifying tumor-infiltrating immune cells from transcriptomics data
Relevance of tumor-infiltrating lymphocytes in breast cancer